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ABSTRACT
We report a rare case of an infective endocarditis by Aerococcus spp in a bioprosthetic 
aortic valve following a prostate biopsy, in an asymptomatic adult with no additional risk 
factor for prostate cancer, excepting for age. The diagnosis was based on the presence of 
vegetations on the bioprosthesis seen on the echocardiogram, positive blood cultures and fever, 
and a favorable clinical outcome following the treatment with ceftriaxone and gentamicin.
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BACKGROUND
Aerococci are Gram-positive, catalase-negative cocci bacteria comprised of 
seven species with similar growth characteristics to those of streptococci and 
enterococci1,2. Generally, they are considered as a contaminant in clinical cultures, 
however A. viridans, A. urinae and A. sanguinicola have been reported as etiologic 
agents in rare cases of bacteremia, urinary tract infections, spondylodiscitis and 
infectious endocarditis (IE)2-6. Risk factors for systemic infections have not yet 
been fully elucidated and a standardized treatment regimen for these pathogens 
are not well established7,8.
To date, less than 20 cases of A. viridans IE have been described in the literature. 
In Brazil, one case was published in 20141. Moreover, along with the rise in the 
use of invasive diagnostic procedures, one case of an infectious complication after 
an inguinal excisional biopsy was described9. Aerococci species determination 
is problematic and proper identification should be based on genetic methods or 
matrix-assisted laser desorption ionization time-of-flight mass spectrometry2,10.
We report a case of Aerococcus spp IE following a prostate biopsy in an 
asymptomatic adult who was screened for prostate cancer. 
CASE REPORT
A 65-year-old man attended the emergency room because of isolated fever 
for five days. Though dysuria was not present, a urinary culture was positive for 
Escherichia coli, and the patient was discharged with a prescription of nitrofurantoin.
After three weeks, he returned to the same emergency room due to the persistence 
of fever despite the use of antibiotics. He reported a weight loss of 7 kg, anorexia 
and adynamia since the onset of symptoms. He had a history of alcoholism, had 
diabetes mellitus diagnosed 5 years before, and degenerative calcified aortic 
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stenosis with valvular replacement by a bioprosthesis three 
years before. One month before the onset of symptoms, a 
prostate cancer screening revealed a total prostatic specific 
antigen (PSA) of 6.27 ng/mL (normal: ≤ 4 ng/mL), a free 
PSA of 0.52 ng/mL (normal: ≤ 0.93 ng/mL), and a prostatic 
biopsy performed without any antibiotic prophylaxis within 
the week in which the patient presented with fever. The 
histopathology result was compatible with usual acinar 
adenocarcinoma, Gleason 3+3.
Dipyrone was administered, and the patient was 
admitted to the hospital for further investigation. The initial 
laboratory evaluation was unremarkable, excepting for a 
normochromic normocytic anemia (Table 1). Ceftriaxone 
2 g every 24 h was initiated.
After admission, the patient developed severe chills and 
the high fever persisted. On examination, the temperature 
was 38.0 ºC, blood pressure was 120/70 mmHg and the heart 
rate was 64 beats per minute. Skin pallor was present. A 
systolic murmur grade 1/4 was best heard in the aortic area. 
The abdomen was soft, and a 2 cm non-tender liver was 
palpable but there was no evidence of an enlarged spleen. 
The remainder of the physical examination was normal.
Abdominal ultrasonography, chest X-ray and 
examination of the urine sediment were unremarkable. 
Blood cultures were collected, and a transesophageal 
echocardiogram (TEE) was performed.
TEE revealed an aortic-valve bioprosthesis with 
severe stenosis (maximum and mean gradient were 86 
and 50 mmHg, respectively; a flow area of 0.54 cm2) and 
a filamentary image highly suggestive of a vegetation, 
measuring 10 mm. Also, vegetations were seen in the 
ascending aorta proximal to the valve annulus. Blood 
cultures isolated an Aerococcus viridans in 3 of 3 flasks 
by using the Vitek 2 Compact System (bioMerieux, Marcy 
l’Etoile, France). All blood culture bottles were collected at 
the same time. The isolate was susceptible to penicillin G, 
ceftriaxone, tigecycline, linezolid, teicoplanin, vancomycin, 
clindamycin and gentamicin. The ceftriaxone regimen was 
maintained, and gentamicin 60 mg every 12 h was initiated 
for a total of 6 weeks.
The patient presented with great improvement, fever and 
chills resolved. The use of gentamicin led to an acute kidney 
injury after two weeks of treatment (creatinine highest level 
1.5 mg/dL). Due to the renal impairment, the cardiothoracic 
surgery staff suggested an elective valve replacement after 
two weeks, and the patient was discharged.
The acute kidney injury resolved, and the infected 
biological valve was successfully replaced after two weeks, 
as planned (Figure 1). Unfortunately, the excised valve was 
not sent to histopathology analysis or to bacterial culturing 
at that time. Regarding the prostate adenocarcinoma, 
radiotherapy was prescribed by the oncologist and the 
patient responded well. 
DISCUSSION
A. viridans is an infrequent human pathogen commonly 
found in dust, raw vegetables, animals, and animal products, 
as well as human skin and urinary tract7,8,11. Other aeroccoci 
have been described as causative agents of IE11. This 
rare infection has been reported in 12 cases worldwide 
(Table 2), one of which is the case of a Brazilian patient1. 
Table 1 - Laboratory data 
Reference range On hospital admission 6th day after admission On discharge
Hb (g/dL) 12-16 8.5 8.6 8.8
Ht (%) 36-46 25.7 27.2 29.4
Leucocytes (cells/mm³) 4,500-11,000 9,200 10,070 10,030
Blasts (%) 0-4 0 0 -
Segmented (%) 45.5-73.5 78 76 73
Lymphocytes (%) 0-4.4 18 22 21
Platelets (10³/mm³) 140-500 231 254 250
Urea (mg/dL) 19.3-49.2 34 64 74
Creatinine (mg/dL) 0.50-1.10 0,8 1.3 1.4
Sodium (mEq/L) 135-145 135 136 137
Potassium (mEq/L) 3.5-5.5 4.5 5.0 5.5
Total bilirrubin (mg/dL) 0-1.2 0.44 - -
Albumin (g/dL) 3.5-4.7 3.7 - -
CRP (mg/dL) < 0.3 - 13.02 3.6
Hb = hemoglobin; Ht = hematocrit; CRP = C-Reactive protein.
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However, among those, only in one of the reports specific 
methodologies were performed to confirm that A. viridans 
was the causative agent7.
In all the reported cases, symptoms and laboratory 
findings were non-specific. Blood cultures and 
echocardiography were essential to provide the final 
diagnosis. In our case, the patient was diagnosed as having 
infective endocarditis due to Aerococcus spp. based on the 
modified Duke’s criteria, including one major criterium 
[vegetation on transesophageal echocardiography (TEE)] 
and three minor criteria (predisposing heart condition, fever 
and positive blood culture)15. Although A. viridans was 
isolated in blood culture, at the time no further confirmatory 
tests were performed. A previous report by Cattoir et al.16 
demonstrated that all eight cases of A. sanguinicola were 
erroneously identified as A. viridans using the Vitek 2 
system. Several isolates identified as A. viridans were 
probably A. sanguinicola, which is more prevalent.
The association of penicillin or a cephalosporin and 
an aminoglycoside was prescribed in eight of the 12 cases 
(66.6%) reported. Surgical approach was chosen in five1,8,11. 
In our case, the ceftriaxone and gentamicin regimen was 
adopted and the patient responded well. 
The prevalence of infectious complications after prostate 
biopsy is about 0.1 to 7%, and antibiotic prophylaxis is 
recommended17. Although cases of IE as an infective 
complication have been described, to our knowledge this 
is the first report of Aerococcus spp IE following a prostate 
biopsy.
Recent randomized clinical trials and meta-analysis 
studies have found that PSA screening leads to early 
cancer detection in asymptomatic men, however, this 
strategy revealed a small or no disease-specific and an 
overall mortality reduction18,19. Our patient developed a 
complication of the prostate biopsy following the PSA 
screening, even though he was asymptomatic and had no 
known risk factors (i.e. black ethnicity, family history or 
Lynch syndrome) for prostate cancer, excepting for age, 
which probably resulted in the overdiagnosis. 










Popescu et al.6 49 M 7 months Ampicillin + Amikacin No No Cure / No relapse
Popescu et al.6 62 M 1 month Ceftriaxone + Amikacin No Yes Cure / No relapse
Popescu et al.6 40 M 3 weeks Penicilin G + Gentamicin No No Cure / No relapse
Popescu et al.6 45 F 3 days Penicilin G + Gentamicin No Yes Cure
Janosek et al.12 10 M 1 month Norfloxacin + Amikacin No Yes Cure
Untereker et al.13 28 M 6 months Penicilin G + Gentamicin No Yes Cure / No relapse




Li et al.15 54 M 4 months Penicilin No No Cure / No relapse
Chen et al.7 58 M 4 days Cefotaxime + Vancomycin No No Cure
Cattoir et al.16 44 F 2 weeks Ampicillin + Gentamicin No No NI
Zhou et al.8 69 M 5 weeks Penicilin No Yes Cure
Orati et al.1 56 F 8 days Ampicilin + Vancomycin No No Cure
M = male; F = female; 16S rRNA = ribosomal RNA subunit 16; NI = not informed
Figure 1 - Aortic valve prosthesis infected with biological explant.
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CONCLUSIONS
This report illustrates a rare case of bioprosthetic aortic 
valve infective endocarditis following a prostate biopsy. We 
could not confirm whether the isolated bacterium was an 
A. viridans or an A. sanguinicola, so that we chose to refer to 
it as an Aerococcus spp. The diagnosis was clinically defined 
by the Duke modified criteria and the patient responded well 
to treatment with ceftriaxone and gentamicin. Clinicians 
should consider prostate cancer screening for selected 
patients and be aware of potential risks and complications.
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